The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series

Autor: Andrea Santangelo, Emanuele Bartolini, Giulia Nuzzi, Thomas Foiadelli, Alexandre Michev, Tommaso Mina, Irene Trambusti, Valeria Fichera, Alice Bonuccelli, Gabriele Massimetti, Diego G. Peroni, Emanuela De Marco, Luca Coccoli, Laura Luti, Sayla Bernasconi, Margherita Nardi, Maria Cristina Menconi, Gabriella Casazza, Dario Pruna, Rosamaria Mura, Chiara Marra, Daniele Zama, Pasquale Striano, Duccio M. Cordelli, Roberta Battini, Alessandro Orsini

Publikováno v: Frontiers in Neurology, Vol 13 (2022)

IntroductionStroke-like syndrome (SLS) is a rare subacute neurological complication of intrathecal or high-dose (≥500 mg) Methotrexate (MTX) administration. Its clinical features, evoking acute cerebral ischaemia with fluctuating course symptoms an

Externí odkaz: https://doaj.org/article/3fb8b8378d5a47a782bcc6546e9e5fd0

Activated Phosphoinositide 3-Kinase Delta Syndrome 1: Clinical and Immunological Data from an Italian Cohort of Patients

Autor: Laura Palumbo, Luisa Gazzurelli, Marco Chiarini, Michael Colpani, Gaetana Lanzi, Maria Federica Girelli, Letizia Brescia, Giorgio Costagliola, Maria Cristina Menconi, Vassilios Lougaris, Alessio Benvenuto, Laura Luti, Maria Pia Bondioni, Raffaele Badolato, Gabriella Casazza, Antonella Meini, Giulio Tessarin, Silvia Giliani, Manuela Baronio, Fiammetta Zunica, Alessandro Plebani, Stefano Rossi, Fabio Cardinale, Daniele Moratto, Francesco Saettini, Baldassarre Martire

Publikováno v: Journal of Clinical Medicine
Volume 9
Issue 10
Journal of Clinical Medicine, Vol 9, Iss 3335, p 3335 (2020)

Activated phosphoinositide 3-kinase delta syndrome 1 (APDS-1) is a recently described inborn error of immunity caused by monoallelic gain-of-function mutations in the PIK3CD gene. We reviewed for the first time medical records and laboratory data of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eee402bbbc31e83ed6a6828f26bb540
http://europepmc.org/articles/PMC7603210

Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

Autor: Margherita Mauro, Paul Bosman, Gloria Tridello, Johanna Tischer, Carlo Dufour, Jerry Stein, Frans J. Smiers, Alicja Chybicka, Isabel Badell, Cécile Pochon, Marta Pillon, Johann Greil, Anne Uyttebroeck, Per Ljungman, Nigel H. Russell, Cristina Tecchio, Maura Faraci, Marc Ansari, Paul Veys, Rahuman Salim, Owen P. Smith, Maria Cristina Menconi, Robert Wynn, Martin Sauer, Jan Styczyński, Franco Locatelli, Gergely Kriván, Patrice Chevalier, Cristina Díaz de Heredia, Régis Peffault de Latour, Simone Cesaro, Tayfun Güngör, Boris V. Afanasyev

Publikováno v: Bone marrow transplantation, Vol. 55, No 9 (2020) pp. 1796-1809
BONE MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Bone Marrow Transplantation. NATURE PUBLISHING GROUP
Bone Marrow Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative procedure in patients with Shwachman–Diamond syndrome (SDS) with bone marrow abnormalities. The results of 74 patients with SDS (6 acute myeloid leukemia, 7 myelodysplastic syn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f9305d11fe89f59b3864da19269822e
https://archive-ouverte.unige.ch/unige:159482

Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma

Autor: Ilaria Pazzagli, Renato Vanacore, Claudio Favre, Carmelo Tibaldi, Carmelo Bengala, Pier Franco Conte, Pierantonio Macchia, Francesco Greco, Alessandro Mazzoni, Maria Cristina Menconi

Publikováno v: Cancer. 85:2295-2296

BACKGROUND As single agents, both paclitaxel and epirubicin in combination with cytokines can mobilize peripheral blood progenitor cells (PBPCs). The authors have demonstrated previously that the combination of epirubicin and paclitaxel is very activ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c0cd2ce0849b9dfc5d3e1e4458f87be
https://doi.org/10.1002/(sici)1097-0142(19990515)85:10<2295::aid-cncr28>3.0.co